In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2V617F allele
- 30 April 2007
- journal article
- Published by Elsevier BV in Experimental Hematology
- Vol. 35 (4), 587-595
- https://doi.org/10.1016/j.exphem.2006.12.007
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Ministerstvo Školství, Mládeže a Tělovýchovy
This publication has 31 references indexed in Scilit:
- Polycythemia vera is not initiated by JAK2V617F mutationExperimental Hematology, 2007
- Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia veraBlood, 2006
- Will radioimmunotherapy replace TBI?Blood, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Triterpenoid Electrophiles (Avicins) Suppress Heat Shock Protein-70 and X-Linked Inhibitor of Apoptosis Proteins in Malignant Cells by Activation of Ubiquitin Machinery: Implications for Proapoptotic ActivityClinical Cancer Research, 2005
- After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignanciesBlood, 2005
- Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry–based novel culture systemBlood, 2003
- Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the diseaseBlood, 2003
- Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivoNature Biotechnology, 2002